Site updated at Wednesday, 22 June 2016

Living with Dementia


Promising Alzheimer’s Drug Fails in Study

Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

The company says that people who received 18 months of infusions with its drug, Gammagard, fared no better than others… Promising Alzheimer’s Drug Fails in Study   


marijuana1 - cinnamon1 - mental impairment1 - diet control1 - berrios and freeman1 - leeza gibbons memory foundation1 - alzheimer's signs1 - symptoms of vascular dementia1 - alzheimer's disease195 - missing person1 - against alzheimer's1 - confabulation1 - degenerative dementia2 - slowness of movement1 - reverse cholesterol transport1 - caregiving2 - semantic dementia1 - behaviours redolent1 - bmi2 - atherosclerotic plaques2 - symptoms of dementia3 - alzheimer's agitation1 - confusion3 - mediterranean and dash1 - atrial fibrillation1 - quality of care2 - pick's disease2 - trichloroethylene1 - alzheimer's brain1 - brain tissue biopsy1 -